Pharmaceutical

Tenpoint raises funds to develop cell therapies for vision loss

Tenpoint Therapeutics has raised Series A funds of $70m for developing engineered cell-based therapies to reverse vision loss.

Jul 13, 2023 - 20:00
Tenpoint raises funds to develop cell therapies for vision loss
Tenpoint Therapeutics has raised Series A funds of $70m for developing engineered cell-based therapies to reverse vision loss.
Read the original article

Tags:

Previous Article

Roche eyes alternate mode of administration for Ocrevus in MS

Next Article

FDA accepts BeiGene’s sNDA for follicular lymphoma therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: FTC sues to block a proposed hospital deal in North Carolina

STAT+: FTC sues to block a proposed hospital deal in No...

Jan 26, 2024

Risk adjusted net present value: What is the current va...

Apr 17, 2024

STAT+: Pharmalittle: Merck to acquire Prometheus Biosciences for $10.8 billion; mRNA cancer vaccine reduces melanoma relapse

STAT+: Pharmalittle: Merck to acquire Prometheus Biosci...

Apr 17, 2023